Published Date:
01 July 2008
BURDICA Biomed has signed a multi-million pound development and licensing contract with an unnamed European medical devices manufacturer.
The Edinburgh-based bio-technology company will supply the base material for a gel filler, which will be injected into clients for lip enhancement and wrinkle reduction. Burdica uses hyaluronic acid for anti-ageing treatments, lubrication and controlled delivery of drugs.
The new product is expected to be registered next year.
-
Last Updated:
30 June 2008 8:53 PM
-
Source:
The Scotsman
-
Location:
Edinburgh
